BSE filing, NSE: VEDL. Summary written from the filing by ALFA Finder's alert engine.
Vedanta Ltd: key numbers
- Share price
- ₹233.05
- Market cap
- ₹91,132 Cr
- Revenue (annual)
- ₹78,437 Cr
- Net profit (annual)
- ₹17,391 Cr
- P/E (TTM)
- 4.6×Sector 16.9×
- Promoter holding
- 54.72%+0.00% QoQ
- FII holding
- 15.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vedanta Ltd
All →Vedanta Earnings Call Transcript: Key Takeaways
Vedanta delivered record revenue and EBITDA driven by operational execution and cost management post-demerger.
Vedanta Results Update
Vedanta files its Q2/H1 FY27 press release and investor presentation alongside board-approved results. The release reports record quarterly performance and declares a ₹5 per share interim dividend.
- Zinc International MIC capacity
- 500 ktpa
Vedanta Q2 FY27 Results: Net Profit ₹6,202 Cr, Up 78.3% YoY
Vedanta Ltd reported revenue from operations of ₹26,356 Cr (+57.5% YoY) and net profit of ₹6,202 Cr (+78.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6,202 Cr · +78.3% YoY
Vedanta Employee Stock Options
Vedanta's NRC approved 99,32,834 performance-based ESOPs under VEDL ESOS 2026. Options vest over 36 months at par value ₹1 per share.
Vedanta Board Meeting Date
Vedanta Ltd scheduled its board meeting for October 28, 2026, to consider Q2/H1 unaudited results. Trading window closes from October 1 to 30 for designated persons.
Vedanta Production Started
Vedanta Limited inaugurated its doubled zinc production capacity to 500,000 tonnes at the Gamsberg site in South Africa, following an investment of nearly US$ 600 million.
- Value
- ₹5,700 Cr
- annual zinc production capacity
- 500000.0 tonnes
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.